Morphosys, Short a clear announcement. In the long position, many were able to enjoy 400%, and selling is currently the order of the day. Target price around 28. In the buying movement there are 92, 128 and 180 on the top, which many traders can be happy about. Good luck and success
Average Analyst Target is 76 !!! Highest is 156. From Volume Analysis we can see that reaccumulation started in Summer. Someone is buying at current prices.
MORPHOSYS had a very strong sell and decline within the last months. Many reasons, two are more important: The cancer drug "Monjuvi" is in delay and apparently there have been troubles in the scientifical research. Secondly, Constellation Pharmaceuticals bought MOR for billions of dollars, a takeover that did not effect the price-action in a positive way. These...
Chart painting from the early 21st century, artist Maxi Scalibusa. No investment advice or a recommendation to buy or sell any securities. This is entertainment. Start 63.80 EUR
Morphosys aquire constellation: www.businesswire.com
As usually, the stock price of the buying company falls down as we see here: www.investopedia.com
Often after the drop, when the merger is successful, the stock may rise.
Morphosys comes on Watchlist for a entry, for a speculative rebound!
I've been browsing the internet for stocks with immense upside and MOR is currently my biggest find! Analyst price target for this one is $166-- a whopping 550% gain to the upside. Short term potential fits nicely in parallel channels for upside of 100%. Don't miss out on this rare find!
MOR was building up bull flag lately. Upper limit (~96 EUR) is close to number limit of 100 EUR. With earnings price cleared 100 EUR first time since Corona crash. Let's wait for confirmation with next swing on hourly timeframe.
Keep observing price-volume disharmony!
Warning of false breakout.
Target: 116 EUR
Entry: 100.84 EUR
Stop: 93 EUR
German Morphosys. Bought this stock due to very positive fundamentals and Analyst reports some weeks ago. Today another (and maybe last) nice possibility to enter after successfull restest of trendline. Analysts confirm target with 90, which fits technical in chart.
